• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Survey reveals top concerns in biopharmas achieving commercial success

Survey reveals top concerns in biopharmas achieving commercial success

March 16, 2012
CenterWatch Staff

Parexel Consulting, a global consultancy service and subsidiary of Parexel International, has released results from a survey polling biopharmaceutical industry professionals, finding that 75% feel the top concern about achieving commercial success is establishing a product price that is reimbursed and accepted by the market.

The survey was conducted at a recent webinar and covered a broad spectrum, including Health Economics and Outcomes Research (HEOR), medical affairs, marketing, reimbursement, and managed markets about the integration of reimbursement strategies in the product development cycle.

While 75% of respondents were concerned with establishing a product price, the remaining 25% believed that developing an Academy of Managed Care Pharmacy (AMCP) or Global Value Dossier supporting favorable review by payers is the top commercialization concern. Furthermore, approximately 63% of respondents claim their organizations wait until phase III clinical trials to start involving various internal commercialization personnel, including reimbursement, market access, pricing, and HEOR functions, in supporting a product, while only 37% involve these functions in product support as early as phase II.

"Our analysis shows that the industry is waiting too long to incorporate reimbursement, patient access, and payment considerations into development. With the industry's top concerns being product price acceptance by the market and favorable payer review, a full complement of commercialization strategies should be analyzed and designed as early as possible in the development process," said Charles A. Stevens, JD, MBA, vice president and general manager, commercialization strategy, Parexel.

"More than ever, it is imperative in this market to prove products demonstrate value to patients, providers, and payers,” Stevens added. “Better reimbursement positioning enables companies to maximize commercial success and support patients in getting access to important products."

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing